Patients and doctors are eager for a noninvasive way to diagnose the disease, and several start-ups are offering new options.

Bailey Ober lost after allowing one run in 4 1/3 innings Sunday night against the White Sox. Ober fanned six in four scoreless innings before giving up a double and an RBI single in the fifth. He ...

The U.S. Department of Agriculture earlier this week approved a genetically modified American chestnut tree developed over decades by scientists at the State University of New York College of ...

The US Food and Drug Administration has cleared Roche and partner Eli Lilly’s blood test to help identify signs of Alzheimer’s disease in people age ‌55 and older with cognitive decline. The test, ...

The FDA cleared the Elecsys Phospho-Tau (217P) Plasma blood test, which Roche and Lilly say is the single-biomarker blood test designed to test for the likelihood of amyloid pathology, a brain symptom ...

Minnesota Twins right-hander Bailey Ober presents an obvious contradiction on the mound. His stride extension still measures 7.2 feet, and the flight profile of his four-seam fastball continues to ...

Add Yahoo as a preferred source to see more of our stories on Google. Ted Stevens, a VENOM test pilot with the 40th Flight Test Squadron, prepares for a test flight June 26, 2026, at Eglin Air Force ...

Ted Stevens, a VENOM test pilot with the 40th Flight Test Squadron, prepares for a test flight June 26, 2026, at Eglin Air Force Base, Florida. (Samuel King Jr./U.S. Air Force) The U.S. Air Force ...

Washington — A blood test may predict if apparently healthy older adults are likely to develop Alzheimer's symptoms in the next five or 10 years, researchers reported Wednesday. That information could ...

Cognitively healthy older adults with high levels of a biomarker called p-tau217 in their blood had an estimated 38% greater chance of developing early signs of dementia over five years, a new study ...

Bailey Ober allowed one run on three hits in five innings in a no-decision against the Guardians on Thursday. It was Ober’s first start since May 30th as he’s been on the IL with elbow inflammation.

Blood tests on the horizon, and under federal regulatory view, may be about to transform cancer care — and survival. The Food and Drug Administration has been evaluating a blood test called Galleri ...